Jun 19, 2017
OTC Disclosure & News Service

ANAHEIM, Calif., June 19, 2017 (GLOBE NEWSWIRE) — Greengro Technologies, Inc. (OTC:GRNH), a world-class provider of eco-friendly horticulture technologies, today announced it has signed a joint venture with Maqsood Rehman, Ph.D., a leading horticulture geneticist, for the development, patenting and licensing of cannabis strains.
The JV is between GenoBreeding, a majority-owned Greengro subsidiary, and Dr. Rehman. Under the terms of the agreement, GenoBreeding will own 60 percent of the JV, and Dr. Rehman 40 percent. As was disclosed just last week, the Company’s GenoBreeding has already signed it first customer, igot420.
Dr. Rehman brings 15 years’ successful experience and industry leadership including five years with Monsanto Company, and five years with Dow Agrosciences. To implement the JV’s business plan for surpassing the current industry state of cannabis strain development, he and his scientific team will utilize advanced technologies including breeding methods, genome sequencing, development of new molecular markers for key traits, and bioinformatics (software tools to develop predictive breeding methods).
The Company is confident its proprietary combination and utilization of these tools, under the painstaking direction of one of the nation’s best qualified plant geneticists, will yield valuable new strains of cannabis and push the edge of the technology to new levels of science. His team includes two master cannabis growers and a molecular genetics and data development scientist.
The combination and relative potency of about 200 terpenes, flavonoids, cannabinoids including THC, CBD and other molecular constituents give various strains of cannabis their distinctive flavors, scents and therapeutic properties. The number of combinations of these constituents, at differing potencies, is unlimited.
The strains GenoBreeding selects for commercialization will be patented, assigned bar codes and included in its growing library for licensing, to companies such as igot420 for example. Initially, the commercialization strategy targets growers, producers and dispensaries seeking their own proprietary marijuana strains, in their own name, to build brand equity as well as to be able to offer customers unique, high quality strains to build brand loyalty. Secondarily, the Company will target the rapidly growing number of biotech firms conducting advanced, FDA compliant clinical research on cannabis from San Diego to Tel Aviv. They require highly specific, custom strains from which to extract and/or synthesize terpenes, CBD and the many other cannabis constituents.
Maqsood Rehman, Ph.D. BiographyMaqsood Rehman, Ph.D. has 15 years’ successful industry experience.  He has worked for Dow Agrosciences since 2012, most recently as Soybean Leader. Prior, he served Monsanto Company since 2007 as Soybean Breeder.
Dr. Rehman has published peer reviewed articles in eight scientific journals. He earned his M.S. and Ph.D. in Plant Science from the University of Idaho, and completed post-doctoral studies at the University of Missouri-Columbia.
About Greengro’s Proprietary GenoBreeding ProgramGreengro’s GenoBreeding program is an advanced initiative in keeping with the cannabis industry’s increasing reliance on genetics. Through the articulate heightening of hereditary attributes and the variation of inherited characteristic in plants, GenoBreeding is creating more robust, healthier, stronger, proprietary commercial cannabis strains that share desirable inherited characteristics.
About Greengro TechnologiesGreengro Technologies (OTC:GRNH) is a world class provider of eco-friendly green technologies with specific domain expertise in indoor and outdoor agricultural science systems serving both the consumer and commercial farming markets. It brings together community and commerce through the growth and distribution of healthy, nutritious foods and vital medicines backed by science and technology. Customers include restaurants, community gardens, and small and large scale commercial clients. Greengro Technologies also provides design, construction and maintenance services to large grow and cultivation operations and collectives in the medical and recreational marijuana sectors.
The company’s website: www.greengrotech.com, offers regular updates including educational videos, projects updates, recipes and nutritional information, and where to find the company’s products. To be added to Greengro’s investor lists, please contact Bill Miller at 844-565-5665 or via email at bmiller@irpartnersinc.com.
Safe HarborThe Company relies upon the Safe Harbor Laws of 1933, 1934 and 1995 for all public news releases. Statements, which are not historical facts, are forward-looking statements. The company, through its management, makes forward-looking public statements concerning its expected future operations, performance and other developments. Such forward-looking statements are necessarily estimates reflecting the company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. It is impossible to identify all such factors. Factors which could cause actual results to differ materially from those estimated by the company include, but are not limited to, government regulation; managing and maintaining growth; the effect of adverse publicity; litigation; competition; and other factors which may be identified from time to time in the company’s public announcements.

Investor/Media Contact:
Bill Miller
Investor Relations Partners
Phone: (844) 565-5665
bmiller@irpartnersinc.com

Company Contact:
James Haas, CEO
Phone: 714-367-6538
info@greengrotech.com

Copyright © 2017 GlobeNewswire. All Rights Reserved
The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.

Related Posts Plugin for WordPress, Blogger...